Dr. James Good is a consultant oncologist renowned for his expertise in gastro-intestinal oncology and stereotactic radiotherapy for metastatic cancer. He advocates for accessible, compassionate, evidence-based, and innovative cancer treatments. Operating across his practices in Birmingham, Oxford, and London, Dr. Good's commitment is unwavering.

Having initially trained as a scientist at Cambridge University, Dr. Good later specialized in cancer medicine and radiotherapy at the Royal Marsden Hospital. In Birmingham, he has led several trials on immunotherapy and novel drug and radiotherapy combinations. Dr. Good played a pivotal role in introducing MRI-guided radiotherapy in the UK, garnering international recognition for its application in liver and pancreatic cancer, as well as secondary tumors.

As the Clinical Director of Stereotactic Radiotherapy at GenesisCare, a prominent private cancer provider, Dr. Good continues to shape the landscape of cancer care. His professional affiliations include memberships in prestigious organizations such as the Royal College of Physicians, the Radiosurgery Society, and the European Society of Medical Oncology. Additionally, he serves as an appointed member of the NCRI Clinical and Translational Radiotherapy Group (CT-Rad) and holds a committee position within the UK SABR Consortium.